GLH's maintenance contract revenue has been declining since 2009 and the acute sector revenue has been the same. It doesn't seem to have the development capability for complex and interconnected large health care system. Non-acute sector is probably where the growth opportunity lies.
I agree with suhm, the current amortization schedule is not appropriate for software asset and there would probably be a write-off if CHIRON is still staying on the book.
The company was expecting a 10% revenue increase. The optimist inside me wants to believe the 1.5 cps is off the new earning and the FY15 NPAT is going to be comparable to FY14. But given how poorly this is communicated it is probably worse than that.
GLH's maintenance contract revenue has been declining since 2009...
Add GLH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
0.005(3.85%) |
Mkt cap ! $7.836M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.5¢ | 13.0¢ | $6.465K | 48.07K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39384 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 1585 | 1 |
View Market Depth
| Last trade - 15.35pm 29/11/2024 (20 minute delay) ? |
| GLH (ASX) Chart |
